Rubric Capital Management (New York)’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,283,690
Closed -$9.24M 101
2022
Q2
$9.24M Buy
+6,283,690
New +$4.62M 0.49% 44

Other funds holding EPZM

Rubric Capital Management (New York)'s EPZM Position: Q3 2022 in Review

Rubric Capital Management (New York) sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 6,283,690 shares — an estimated $9.24M sold.

Rubric Capital Management (New York) first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $9.24M in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

  • Rubric Capital Management (New York) reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
  • Rubric Capital Management (New York) sold 6,283,690 Epizyme, Inc shares in Q3 2022, an estimated $9.24M.
  • Rubric Capital Management (New York) first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
  • Rubric Capital Management (New York)'s Epizyme, Inc position peaked at $9.24M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Rubric Capital Management (New York)'s 13F filing for Q3 2022, filed 14 Nov 2022.